This post is sponsored by the Ohio Venture Association.
Startup-friendly firms and venture capital combined to breathe life into the business of a local doctor who helps patients breathe.
Dr. Raymond Onders will share a venture capital success story this week during his talk, “Helping Patients Breathe: From Superman to Synapse Biomedical — How orphan diseases can lead to worldwide sales from Northeastern Ohio.”
Onders, Director of Minimally Invasive Surgery at Synapse Technology Corp., will speak at the Ohio Venture Association luncheon on Friday, Oct. 8 at The Union Club in Cleveland. The event begins with networking at 11:30 a.m. and ends at 1:30 p.m. Lunch will be served at noon.
A Cleveland native, Onders attended Kent State University and Northeastern Ohio Universities Colleges of Medicine, which recently honored him with the Distinguished Alumni Award–its highest award–for his work in helping advance medicine.
A former U.S. Air Force Major, Onders was the first Director of Minimally Invasive Surgery at CWRU School of Medicine. Over the last 12 years in Cleveland, Onders has focused his research on ways to help people breathe naturally using their own diaphragms. He has written more than 100 papers, book chapters and published abstracts. When Onders was researching how to help spinal cord injury patients breathe without a ventilator, one of his first research subjects was the late actor Christopher Reeve, who played Superman.
Onders’ research and work in helping patients has led to numerous honors, including: The Maurice Saltzman Award presented on behalf of the Mt. Sinai Health Care Foundation; Northern Ohio Live Award of Achievement in Science and Technology; Crain’s Cleveland Business 2008 Health Care Heroes for Advancement in Health; and the prestigious Margaret and Walter Remen Chair of Surgical Innovation at University Hospitals Case Medical Center and CWRU School of Medicine.
Advancements that Onders has made in the technology of pacing the diaphragm have led to patents and to the founding of Synapse Biomedical to bring this technology to patients. In 2003, Synapse Biomedical was the runner-up for TIIME, CWRU/Weatherhead Business School Business Launch Competition in the Bioscience Category and Best in Show in the 2003 Cleveland Growth Association/COSE Business Plan Challenge.
Through the work and help of JumpStart, BioEnterprise and many other local entities, and with venture capital investments from California, Synapse Biomedical continues to grow. Sales are expanding worldwide. Future pipeline products will help patients with Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) and any patient on a ventilator in the case of a pandemic.
Members may attend the luncheon for $25 with a reservation or $35 without a reservation. For non-members, the cost is $45 with a reservation or $55 without a reservation. To register, go to www.ohioventure.org.